article thumbnail

March 6, 2024: In This Week’s PCT Grand Rounds, Public-Private Partnerships in Health AI

Rethinking Clinical Trials

Pencina is a professor of biostatistics and bioinformatics and the vice dean for data science in the Duke University School of Medicine. He is the director of the university’s Duke AI Health initiative and the chief data scientist for Duke Health. Join the online meeting.

article thumbnail

Clinical Scientist Jobs: The Steps to Succeed in This Role

XTalks

If you enjoy working with biological samples and are enthusiastic about healthcare, a career as a clinical scientist might be just right for you. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform. Who is a Clinical Scientist? What is it Like to Work as a Clinical Scientist?

Scientist 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Physicians and scientists join forces to develop the longevity medicine curriculum

Scienmag

Physicians and scientists highlight the importance of longevity medicine education and collaborate on the first longevity medicine course for physicians Credit: © Mary Mitina 16th of March, Tuesday, 2021 — Longevity medicine is a rapidly evolving branch of preventative precision medicine that is specifically focused on promoting healthspan and (..)

article thumbnail

DDW seminar on AI and automation at ELRIG Drug Discovery 2022 

Drug Discovery World

will be discussing The Role of AI and Automation in Personalised Medicine: How can AI Help in The Post Drug Discovery Process.?? . Dr Anvar was a senior scientist before joining OKRA, serving as the principal investigator of preclinical personalised medicine. Yahya Anvar, Head of Data Science Okra.AI

Drugs 52
article thumbnail

Scientists at IRB Barcelona identify a potential target to treat lung cancer

Scienmag

Credit: IRB Barcelona In cancer, personalised medicine takes advantage of the unique genetic changes in an individual tumour to find its vulnerabilities and fight it. Many tumours have a higher number of mutations due to a antiviral defence mechanism, the APOBEC system, which can accidentally damage DNA and cause mutations.

article thumbnail

Forty of the Nation’s Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021

The Pharma Data

The finalists were selected based on their projects’ scientific rigor and their potential to become world-changing scientists and leaders. They will also have an opportunity to interact with leading scientists and display their projects to the public during a virtual event on March 14. million in awards. Yancopoulos , M.D.,

article thumbnail

Cancer Research UK partnership aims to back 10 new startups

pharmaphorum

DSV’s involvement will provide pre-seed capital for the new ventures, which will be incubated within Cancer Research Horizon’s wet labs with support from scientists among its researcher network. The post Cancer Research UK partnership aims to back 10 new startups appeared first on.